Seeking Alpha

cmcfarling

cmcfarling
Send Message
View as an RSS Feed
View cmcfarling's Comments BY TICKER:
Latest  |  Highest rated
  • iBio Is Not The Partner Of Mapp's Ebola Drug [View article]
    You completely failed to mention Caliber Biotherapeutics and their partnership with iBio. The CHO method "may" be viable at some point in the future but it hasn't even produced 1 dose of ZMapp yet. It will take months to get that process in place, if it even works.

    Caliber/iBio is ready to go NOW. Caliber, employing iBio's iBioLaunch technology, can be in large scale production in a couple of weeks. Kind of important if you only have a few weeks to live once contracting ebola.
    Oct 13, 2014. 12:49 PM | 6 Likes Like |Link to Comment
  • iBio Is Not The Partner Of Mapp's Ebola Drug [View article]
    So maybe it's a buyout target then. Anything is possible and the fact of the matter is that there is no where near enough ZMapp currently. This is the only drug that has shown any real efficacy in fighting off Ebola. A price of $3.00 would put it at an all time high accounting for changes in O/S. I think it could easily surpass that. This outbreak could get much, much worse over the coming weeks and months.

    A positive PR from Caliber Biotherapeutics confirming that they have been contracted to produce ZMapp on a large scale and this goes parabolic.
    Oct 13, 2014. 12:23 PM | Likes Like |Link to Comment
  • iBio Is Not The Partner Of Mapp's Ebola Drug [View article]
    Don't expect a reply. His intent was to mislead.
    Oct 13, 2014. 12:17 PM | 5 Likes Like |Link to Comment
  • iBio Is Not The Partner Of Mapp's Ebola Drug [View article]
    iBio hit piece. iBio is partners with Caliber Biotherapeutics who IS working with government agencies to ramp up production of ZMapp. Caliber Biotherapeutics has the the capacity to produce 20000 doses of ZMapp. The CHO method hasn't even been tested yet.
    Oct 13, 2014. 09:26 AM | 11 Likes Like |Link to Comment
  • InVivo's Day Has Arrived [View article]
    Don't forget, from 3/17...

    "The Company also announced that, as a result of ongoing discussions with clinical experts, we are reviewing non-traumatic spinal cord impairment indications that could benefit from our device. This effort could result in additional uses of the scaffold and may expand the entire development program."

    If they determine that the device is safe, there could many uses for the technology. The thought process is this...

    Human trials must be done initially with scaffold alone to prove safety. That leaves the option to conduct trials an acute SCI or chronic SCI patients. In either case the results in regard to safety would likely be the same. So pick the one that also the most chance to show improvement to the injury. Acute SCI wins.
    May 1, 2014. 03:05 PM | 1 Like Like |Link to Comment
  • InVivo's Day Has Arrived [View article]
    If you have been injured and will likely be a 6 on the BBB scale, what would you do to get to an 8 or 9? Would you let a surgeon implant a small sponge-like device in your spinal cord that will dissolve in a few weeks that MAY make your condition better? I think I would. Anything closer to full functionality has to be better even if it's a couple of steps on the scale. That may mean 10%, 20%, 30% less that you have to rely on someone else for the rest of your life to help you with comman day-to-day activities. It may turn out that the scaffold alone does nothing for you, but so what, that's where you were anyway.

    The improvements with the scaffold alone in the animal studies cannot simply be ignored or discounted. If the human scaffold does nothing this trial is a success because this trial is intended just to determine safety. If improvements are shown (which I believe will happen) then that is icing on the cake. Of course if the patients are determined to be worse off then NVIV is worth $0. That scenario is extremely unlikely. Again the animal data can't be ignored and there are some very smart people who have spent enormous amounts of time pondering if this will work.

    5% chance that scaffold is harmful
    35% chance it does nothing
    60% chance it improves the condition
    May 1, 2014. 02:21 PM | 3 Likes Like |Link to Comment
  • InVivo's Day Has Arrived [View article]
    No mention of hydrogel. Curious what Perrin had to say about that.
    Apr 30, 2014. 08:17 AM | 1 Like Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    "If it turns out that there is nothing rotten in the state of Growlife" then there's no reason to bash Brochstein. You're jumping the gun a bit don't you think?
    Apr 15, 2014. 09:23 AM | 3 Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    Yes and Brochstein has been cautioning of the FSPM share structure for months.
    Apr 15, 2014. 09:20 AM | Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    Yes, the buyers of NFLX at $458 can hold their head high knowing that they have lost 28% of their investment on a well vetted company. LOL.

    No basis for investment decisions? Come on. There is news and filings constantly, just like any exchange traded stock. Your argument is against the OTC in general. You can either embrace the OTC for what it is and invest accordingly or simply stay away and stick to perceived "safer" investments.
    Apr 15, 2014. 09:18 AM | 6 Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    The irony is that the SEC is hurting investors more than if they had done nothing. So what if the valuations are high. Everyone knows that and if you don't it's your own fault. What's worse, buying PHOT at $.78 or NFLX at $458? Not much difference really.
    Apr 15, 2014. 03:02 AM | 25 Likes Like |Link to Comment
  • Growlife: Taking A Page From Amazon [View article]
    Hence the recent vote to raise the A/S to 3 billion.
    Apr 2, 2014. 01:40 AM | 1 Like Like |Link to Comment
  • Nokia: Yes To QWERTY Nokia X And Lumia Phones [View article]
    I hate on-screen keyboards for anything other than a short message. As a sys admin I also hate trying to walk users through configuring things on their phone remotely. A slide out QWERTY phone is a no brainer IMO, you get the best of both worlds. So what if it's slightly thicker. IF MS would build remote access into the Windows Phone OS then phones could managed remotely just like PCs. The combination of the two would make for a huge advantage in the corporate market.
    Mar 30, 2014. 01:18 AM | 2 Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    I looked into SING. It doesn't look like there's much there there. Their technology is like a poor man's Google wallet. Anyone who would use their software would be better off just using a credit card swiping terminal.
    Mar 17, 2014. 10:34 PM | Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    The same advertising that PHOT used last year. Was that gratuitous?
    Mar 16, 2014. 12:35 PM | Likes Like |Link to Comment
COMMENTS STATS
79 Comments
192 Likes